Clinical consultations and investigations before and after discontinuation of endocrine therapy in women with primary breast cancer

• Main Authors: Derrick Lopez (Author), Anna Kemp-Casey (Author), Christobel Saunders (Author), Elizabeth Roughead (Author), Frances Boyle (Author), Max Bulsara (Author), David Preen (Author)
• Format: Book
• Published: Sax Institute, 2017-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: Although clinical trials recommend that women with hormone-dependent primary breast cancer remain on endocrine therapy for at least 5 years, up to 60% discontinue treatment early. We determined whether these women had consulted with clinicians or had investigations for cancer recurrence o...